Reactivity of genotype-specific recombinant proteins of human erythrovirus B19 with plasmas from areas where genotype 1 or 3 is endemic

Journal of Clinical Microbiology

Volumn 44, Issue 4, 2006, Pages 1367-1375

  Parsyan, Armen ^a,b   Kerr, Shane ^c   Owusu Ofori, Shirley ^d   Elliott, Gordon ^c   Allain, Jean Pierre ^a,e  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

^c Biotrin International   (Ireland)

^d KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

^e Cambridge Blood Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; PROTEIN VP1; PROTEIN VP2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS CAPSID ANTIGEN; VIRUS GENOTYPE SPECIFIC ANTIGEN; VIRUS PROTEIN;

ADULT; ANTIBODY CAPTURE; ANTIBODY DETECTION; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; CROSS REACTION; ENZYME IMMUNOASSAY; GHANA; HUMAN; IMMUNOREACTIVITY; KAPPA STATISTICS; MAJOR CLINICAL STUDY; MOLECULAR EPIDEMIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARVOVIRUS; PARVOVIRUS GENOTYPE 1; PARVOVIRUS GENOTYPE 2; PARVOVIRUS GENOTYPE 3; PLASMA; PRIORITY JOURNAL; RELIABILITY; UNITED KINGDOM; VIRUS DETECTION;

ANTIGENS, VIRAL; CAPSID; CHILD; CHILD, PRESCHOOL; CROSS REACTIONS; ENDEMIC DISEASES; GENOTYPE; GREAT BRITAIN; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; RECOMBINANT PROTEINS;

ERYTHROVIRUS; MIRIDAE; PARVOVIRUS;

EID: 33645901206     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.4.1367-1375.2006     Document Type: Article

References (39)

1. Aceti, A., G. Taliani, C. de Bac, and A. Sebastiani. 1990. Anti-HCV false positively in malaria. Lancet 336:1442-1443.
2. Ampofo, W., N. Nii-Trebi, J. Ansah, K. Abe, H. Naito, S. Aidoo, V. Nuvor, J. Brandful, N. Yamamoto, D. Ofori-Adjei, and K. Ishikawa. 2002. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J. Clin. Microbiol. 40:3523-3525.
3. Bansal, G. P., J. A. Hatfield, F. E. Dunn, A. A. Kramer, F. Brady, C. H. Riggin, M. S. Collett, K. Yoshimoto, S. Kajigaya, and N. S. Young. 1993. Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis. 167:1034-1044.
4. Brown, C. S., J. W. Van Lent, J. M. Vlak, and W. J. Spaan. 1991. Assembly of empty capsids by using baculovirus recombinants expressing human parvovirus B19 structural proteins. J. Virol. 65:2702-2706.
5. Brown, K. E., Z. Liu, G. Gallinella, S. Wong, I. P. Mills, and M. G. O'Sullivan. 2004. Simian parvovirus infection: a potential zoonosis. J. Infect. Dis. 190:1900-1907.
6. Candotti, D., N. Etiz, A. Parsyan, and J. P. Allain. 2004. Identification and characterization of persistent human erythrovirus infection in blood donor samples. J. Virol. 78:12169-12178.
7. Corcoran, A., S. Doyle, J. P. Allain, D. Candotti, and A. Parsyan. 2005. Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections. J. Virol. 79:5238-5239.
8. Cotmore, S. F., V. C. McKie, L. J. Anderson, C. R. Astell, and P. Tattersall. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J. Virol. 60:548-557.
9. Cotmore, S. F., and P. Tattersall. 1984. Characterization and molecular cloning of a human parvovirus genome. Science 226:1161-1165.
10. Dawson, B., and R. G. Trapp. 2001. Basic and clinical biostatistics, 3rd ed. McGraw-Hill, New York, N.Y.
11. Delaporte, E., M. Peeters, F. Simon, A. Dupont, D. Schrijvers, D. Kerouedan, R. Josse, M. Merlin, A. Trebucq, M. Collet, et al. 1989. Interpretation of antibodies reacting solely with human retroviral core proteins in western equatorial Africa. AIDS 3:179-182.
12. Erdman, D. D., M. J. Usher, C. Tsou, E. O. Caul, G. W. Gary, S. Kajigaya, N. S. Young, and L. J. Anderson. 1991. Human parvovirus B19 specific IgG, IgA, and IgM antibodies and DNA in serum specimens from persons with erythema infectiosum. J. Med. Virol. 35:110-115.
13. Heegaard, E. D., I. Panum Jensen, and J. Christensen. 2001. Novel PCR assay for differential detection and screening of erythrovirus B19 and erythrovirus V9. J. Med. Virol. 65:362-367.
14. Heegaard, E. D., K. Qvortrup, and J. Christensen. 2002. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. J. Med. Virol. 66:246-252.
15. Hicks, K. E., R. C. Cubel, B. J. Cohen, and J. P. Clewley. 1996. Sequence analysis of a parvovirus B19 isolate and baculovirus expression of the non-structural protein. Arch. Virol. 141:1319-1327.
16. Hokynar, K., M. Soderlund-Venermo, M. Pesonen, A. Ranki, O. Kiviluoto, E. K. Partio, and K. Hedman. 2002. A new parvovirus genotype persistent in human skin. Virology 302:224-228.
17. Kajigaya, S., H. Fujii, A. Field, S. Anderson, S. Rosenfeld, L. J. Anderson, T. Shimada, and N. S. Young. 1991. Self-assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc. Natl. Acad. Sci. USA 88:4646-4650.
18. Kuhls, T. L., P. G. Nishanian, J. D. Cherry, J. P. Shen, C. G. Neumann, E. R. Stiehm, R. B. Ettenger, N. O. Bwibo, and D. Koech. 1988. Analysis of false positive HIV-1 serologic testing in Kenya. Diagn. Microbiol. Infect. Dis. 9:179-185.
19. Manaresi, E., G. Gallinella, A. M. Morselli Labate, P. Zucchelli, D. Zaccarelli, S. Ambretti, S. Delbarba, M. Zerbini, and M. Musiani. 2004. Seroprevalence of IgG against conformational and linear capsid antigens of parvovirus B19 in Italian blood donors. Epidemiol. Infect. 132:857-862.
20. Manaresi, E., G. Gallinella, S. Venturoli, M. Zerbini, and M. Musiani. 2004. Detection of parvovirus B19 IgG: choice of antigens and serological tests. J. Clin. Virol. 29:51-53.
21. Manaresi, E., E. Zuffi, G. Gallinella, G. Gentilomi, M. Zerbini, and M. Musiani. 2001. Differential IgM response to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins. J. Med. Virol. 64:67-73.
22. Nguyen, Q. T., C. Sifer, V. Schneider, F. Bernaudin, V. Auguste, and A. Garbarg-Chenon. 1998. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet 352:1524.
23. Nguyen, Q. T., S. Wong, E. D. Heegaard, and K. E. Brown. 2002. Identification and characterization of a second novel human erythrovirus variant, A6. Virology 301:374-380.
24. O'Sullivan, M. G., D. C. Anderson, J. D. Fikes, F. T. Bain, C. S. Carlson, S. W. Green, N. S. Young, and K. E. Brown. 1994. Identification of a novel simian parvovirus in cynomolgus monkeys with severe anemia. A paradigm of human B19 parvovirus infection. J. Clin. Invest. 93:1571-1576.
25. Ozawa, K., J. Ayub, Y. S. Hao, G. Kurtzman, T. Shimada, and N. Young. 1987. Novel transcription map for the B19 (human) pathogenic parvovirus. J. Virol. 61:2395-2406.
26. Ozawa, K., J. Ayub, and N. Young. 1988. Functional mapping of the genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selection. J. Virol. 62:2508-2511.
27. Ozawa, K., and N. Young. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J. Virol. 61:2627-2630.
28. 27a. Parsyan, A., et al. Effects of transfusion on human erythrovirus B19 susceptible or infected pediatric recipients in a genotype 3 endemic area. Transfusion, in press.
29. Rosenfeld, S. J., N. S. Young, D. Alling, J. Ayub, and C. Saxinger. 1994. Subunit interaction in B19 parvovirus empty capsids. Arch. Virol. 136:9-18.
30. Rouet, F., M. L. Chaix, A. Inwoley, P. Msellati, I. Viho, P. Combe, V. Leroy, F. Dabis, and C. Rouzioux. 2004. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: the ANRS 1236 study. J. Med. Virol. 74:34-40.
31. Salimans, M. M., M. J. van Bussel, C. S. Brown, and W. J. Spaan. 1992. Recombinant parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay. J. Virol. Methods 39:247-258.
32. Servant, A., S. Laperche, F. Lallemand, V. Marinho, G. De Saint Maur, J. F. Meritet, and A. Garbarg-Chenon. 2002. Genetic diversity within human erythroviruses: identification of three genotypes. J. Virol. 76:9124-9134.
33. Summers, J., S. E. Jones, and M. J. Anderson. 1983. Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus. J. Gen. Virol. 64:2527-2532.
34. Tess, B. H., A. Levin, G. Brubaker, J. Shao, J. E. Drummond, H. J. Alter, and T. R. O'Brien. 2000. Seroprevalence of hepatitis C virus in the general population of northwest Tanzania. Am. J. Trop. Med. Hyg. 62:138-141.
35. Thomas, I., M. Di Giambattista, C. Gerard, E. Mathys, V. Hougardy, B. Latour, T. Branckaert, and R. Laub. 2003. Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins. Vox Sang. 84:300-307.
36. Trepo, C., F. Zoulim, C. Alonso, M. A. Petit, C. Pichoud, and L. Vitvitski. 1993. Diagnostic markers of viral hepatitis B and C. Gut 34:S20-S25.
37. Van Kerckhoven, I., G. Vercauteren, P. Piot, and G. van der Groen. 1991. Comparative evaluation of 36 commercial assays for detecting antibodies to HIV. Bull. W. H. O. 69:753-760.
38. Wong, S., M. Momoeda, A. Field, S. Kajigaya, and N. S. Young. 1994. Formation of empty B19 parvovirus capsids by the truncated minor capsid protein. J. Virol. 68:4690-1694.
39. Young, N. S., and K. E. Brown. 2004. Parvovirus B19. N. Engl. J. Med. 350:586-597.